Additional Proxy Soliciting Materials (definitive) (defa14a)
October 30 2020 - 11:21AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE 14A
Proxy
Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No.
)
|
|
|
|
Filed
by the Registrant ⌧
|
|
Filed
by a Party other than the Registrant ☐
|
|
Check
the appropriate box:
|
☐
|
Preliminary Proxy
Statement
|
☐
|
Confidential,
for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
|
☐
|
Definitive Proxy
Statement
|
⌧
|
Definitive
Additional Materials
|
☐
|
Soliciting
Material under §240.14a-12
|
|
AMPIO PHARMACEUTICALS, INC.
|
(Name
of Registrant as Specified In Its Charter)
|
|
|
(Name
of Person(s) Filing Proxy Statement, if other than the
Registrant)
|
|
Payment of Filing
Fee (Check the appropriate box):
|
⌧
|
No fee
required.
|
☐
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
|
|
(1)
|
Title
of each class of securities to which transaction
applies:
|
|
|
|
|
(2)
|
Aggregate number
of securities to which transaction applies:
|
|
|
|
|
(3)
|
Per
unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was
determined):
|
|
|
|
|
(4)
|
Proposed maximum
aggregate value of transaction:
|
|
|
|
|
(5)
|
Total
fee paid:
|
|
|
|
☐
|
Fee
paid previously with preliminary materials.
|
☐
|
Check
box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by
registration statement number, or the Form or Schedule and the date
of its filing.
|
|
(1)
|
Amount
Previously Paid:
|
|
|
|
|
(2)
|
Form,
Schedule or Registration Statement No.:
|
|
|
|
|
(3)
|
Filing
Party:
|
|
|
|
|
(4)
|
Date
Filed:
|
|
|
|
|
|
|
|

|
***
Exercise Your Right to Vote *** Important Notice Regarding the
Availability of Proxy Materials for the Stockholder Meeting to Be
Held on December 12, 2020. AMPIO PHARMACEUTICALS, INC. AMPIO
PHARMACEUTICALS, INC. 373 INVERNESS PARKWAY, SUITE 200 ENGLEWOOD,
CO 80112 You are receiving this communication because you hold
shares in the company named above. This is not a ballot. You cannot
use this notice to vote these shares. This communication presents
only an overview of the more complete proxy materials that are
available to you on the Internet. You may view the proxy materials
online at www.proxyvote.com or easily request a paper copy (see
reverse side). We encourage you to access and review all of the
important information contained in the proxy materials before
voting. proxy materials and voting instructions. D26354-P45144 See
the reverse side of this notice to obtain Meeting Information
Meeting Type: Annual Meeting For holders as of: October 16, 2020
Date: December 12, 2020 Time: 9:00 AM, MT Location: Meeting live
via the Internet-please visit
www.virtualshareholdermeeting.com/AMPE2020. The company will be
hosting the meeting live via the Internet this year. To attend the
meeting via the Internet please visit
www.virtualshareholdermeeting.com/AMPE2020 and be sure to have the
information that is printed in the box marked by the arrow (located
on the following page). XXXX XXXX XXXX XXXX
|

|
Before
You Vote How to Access the Proxy Materials How To Vote Please
Choose One of the Following Voting Methods D26355-P45144 Vote By
Internet: Before The Meeting: Go to www.proxyvote.com. Have the
information that is printed in the box marked by the arrow (located
on the following page) available and follow the instructions.
During The Meeting: Go to
www.virtualshareholdermeeting.com/AMPE2020. Have the information
that is printed in the box marked by the arrow(located on the
following page) available and follow the instructions. Vote By
Mail: You can vote by mail by requesting a paper copy of the
materials, which will include a proxy card. XXXX XXXX XXXX XXXX
XXXX XXXX XXXX XXXX Proxy Materials Available to VIEW or RECEIVE:
NOTICE AND PROXY STATEMENTFORM 10-K How to View Online: Have the
information that is printed in the box marked by the arrow(located
on the following page) and visit: www.proxyvote.com. How to Request
and Receive a PAPER or E-MAIL Copy: If you want to receive a paper
or e-mail copy of these documents, you must request one. There is
NO charge for requesting a copy. Please choose one of the following
methods to make your request: 1) BY INTERNET:www.proxyvote.com 2)
BY TELEPHONE:1-800-579-1639 3) BY
E-MAIL*:sendmaterial@proxyvote.com * If requesting materials by
e-mail, please send a blank e-mail with the information that is
printed in the box marked by the arrow(located on the following
page) in the subject line. Requests, instructions and other
inquiries sent to this e-mail address will NOT be forwarded to your
investment advisor. Please make the request as instructed above on
or before November 28, 2020 to facilitate timely delivery. XXXX
XXXX XXXX XXXX XXXX XXXX XXXX XXXX
|

|
The
Board of Directors recommends you vote FOR the following: 1. To
elect five directors, nominated by our Board of Directors, to serve
until our 2021 Annual Meeting of Stockholders and until their
respective successors are duly elected and qualified or their
earlier resignation or removal. Nominees: 01) 02) 03) 04) 05)
Michael Macaluso David Bar-Or, M.D. Philip H. Coelho Richard B.
Giles David R. Stevens, Ph.D. The Board of Directors recommends you
vote FOR proposal 2. 2. To ratify the selection of Moss Adams LLP
as our independent registered public accounting firm for the fiscal
year ending December 31, 2020. Note: To transact such other
business as may properly come before the meeting or any
adjournment(s) thereof. D26356-P45144 Voting Items
|

|
D26357-P45144
|